Allergan Settles Patent Litigation With Cadila and Zydus Pharma


Allergan has announced that it has settled patent litigation with Cadila Healthcare and Zydus Pharmaceuticals. The patent litigation in regards to Cadila and Zydus’ attempts to develop a generic version of Delzicol, an Allergan drug treating ulcerative colitis. Under the terms of the Allergan settlement, Cadila and Zydus may begin selling their generic version of Delzicol on March 1st, 2020.

Read the source article at Market Watch

About the Author

Related Posts

Leave a Reply